Accendra Health Stock

Accendra Health ROE

The Return on Equity (ROE) of Accendra Health (ACH) as of Aug 16, 2026 is 238.76 %. In the previous year, Return on Equity (ROE) was -64.17 % — a change of -472.10% (higher).

ROE

238.76 %

YoY

-472.10%

Last updated:

In 2026, Accendra Health's return on equity (ROE) was 238.76 %, a -472.10% increase from the -64.17 % ROE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Accendra Health Stock analysis

What does Accendra Health do? Owens & Minor Inc. is a global company that specializes in supplying medical products and supply chain solutions. They have been in operation since 1882 and have become a leading provider in the industry. The company works with various suppliers and manufacturers to ensure a wide range of products and reliable delivery. They have three different business segments: Medical, Surgical, and Global Products. Owens & Minor focuses on efficiency in procurement and supply chain management, using advanced technology and processes. They also prioritize quality and sustainability, with certifications like ISO 13485. Overall, Owens & Minor is dedicated to delivering quality medical supplies and devices worldwide. Accendra Health is one of the most popular companies on Eulerpool.

ROE Details

Decoding Accendra Health's Return on Equity (ROE)

Accendra Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Accendra Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Accendra Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Accendra Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Accendra Health stock

Return on Equity (ROE) of Accendra Health is 238.76 % in 2026.

Return on Equity (ROE) of Accendra Health changed from -64.17 % to 238.76 %, representing a -472.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Accendra Health since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Accendra Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Accendra Health

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Accendra Health